AbbVie Raises its Bid for Shire, Offers Shareholders More

AbbVie is offering a cash-stock combination valued at $91.10 for each share of Shire
July 15, 2014

AbbVie and Shire have started negotions again after AbbVie raised its bid and offered to give Shire shareholders a bigger stake in the resulting company. Shire said that AbbVie is now offering a cash-stock combination valued at $91.10 for each share of Shire. The new offer totals roughly $53.68 billion and represents an increase from AbbVie's previous proposal, which amounted to more than $51 billion. Read the full story

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates